MA40417A - Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques - Google Patents
Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiquesInfo
- Publication number
- MA40417A MA40417A MA040417A MA40417A MA40417A MA 40417 A MA40417 A MA 40417A MA 040417 A MA040417 A MA 040417A MA 40417 A MA40417 A MA 40417A MA 40417 A MA40417 A MA 40417A
- Authority
- MA
- Morocco
- Prior art keywords
- acid
- fatty acids
- palmitoylethanolamide
- inflammatory
- mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La présente invention concerne un mélange contenant jusqu'à deux acides gras choisis entre l'acide palmitique, l'acide oléique, l'acide stéarique, l'acide linoléique, l'acide alpha-linolénique, l'acide gamma-linolénique, l'acide eicosapentaénoïque, l'acide docosahexaénoïque, l'acide azélaïque et l'acide myristique, et du palmitoyl éthanolamide. Dans un mode de réalisation de la présente invention ledit mélange est caractérisé en ce qu'au moins l'un desdits acides gras est saturé. La présente invention con
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20141474 | 2014-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40417A true MA40417A (fr) | 2017-06-14 |
Family
ID=51663273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA040417A MA40417A (fr) | 2014-08-08 | 2015-08-03 | Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques |
Country Status (12)
Country | Link |
---|---|
US (2) | US9962355B2 (fr) |
EP (1) | EP3177281B1 (fr) |
JP (3) | JP7118642B2 (fr) |
CN (1) | CN106714792A (fr) |
CA (1) | CA2957700C (fr) |
CO (1) | CO2017001088A2 (fr) |
DK (1) | DK3177281T3 (fr) |
FI (1) | FI3177281T3 (fr) |
IL (1) | IL250271B2 (fr) |
MA (1) | MA40417A (fr) |
TW (1) | TWI727926B (fr) |
WO (1) | WO2016020828A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017062699A1 (fr) * | 2015-10-07 | 2017-04-13 | Cormedix Inc. | Formulation de pénétration cutanée à base de taurolidine |
CN109893520A (zh) * | 2019-03-21 | 2019-06-18 | 中国科学院水生生物研究所 | 螺旋藻γ-亚麻酸的新用途 |
EP3955747A4 (fr) * | 2019-04-15 | 2023-02-01 | Metagenics, Inc. | Nouvelle formulation de chanvre et de pois et son utilisation |
IT202100024464A1 (it) * | 2021-09-23 | 2023-03-23 | Epitech Group S P A | N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive |
CN114209683A (zh) * | 2021-12-22 | 2022-03-22 | 中南大学湘雅三医院 | 壬二酸在制备治疗炎症性肠病药物中的应用 |
BR112023010845A2 (pt) * | 2022-03-14 | 2023-10-24 | Fera Diagnostics And Biologicals Corp | Composições de ácido graxo e métodos |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1252865B (it) * | 1991-12-31 | 1995-06-28 | Lifegroup Spa | N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni |
US5679667A (en) * | 1992-04-24 | 1997-10-21 | Lifegroup S.P.A. | Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve |
IT1257697B (it) * | 1992-04-24 | 1996-02-01 | Lifegroup Spa | N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico. |
EP0644764B1 (fr) * | 1992-06-19 | 2000-05-17 | The Regents of the University of California | Lipides pour l'humidification de l'epiderme et la restauration de la fonction de barriere |
EP0620000A3 (fr) * | 1992-12-18 | 1994-11-02 | Rhone-Poulenc Rorer Gmbh | Utilisation cosmétique et/ou pharmaceutique des N-acylalcanolamines |
US5599548A (en) * | 1995-05-08 | 1997-02-04 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides and retinol or retinyl ester |
US5716627A (en) * | 1996-04-25 | 1998-02-10 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester |
JP2000159668A (ja) * | 1998-11-26 | 2000-06-13 | Nof Corp | サイトカイン抑制剤 |
JP2000191525A (ja) * | 1998-12-25 | 2000-07-11 | Nof Corp | 皮膚外用剤組成物 |
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
US20020143059A1 (en) * | 2000-12-28 | 2002-10-03 | Sreekumar Pillai | Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
DE10217131A1 (de) * | 2001-07-31 | 2003-02-13 | Kuhs Kosmetik Gmbh & Co Kg | Topisch applizierbare Zusammensetzung sowie Werkstoffgemisch |
US7447631B2 (en) | 2002-06-17 | 2008-11-04 | Dolby Laboratories Licensing Corporation | Audio coding system using spectral hole filling |
DE602006013787D1 (de) * | 2006-03-28 | 2010-06-02 | Epitech Group Srl | Eine Pharmazeutische Zusammensetzung zur Behandlung von Pathologien, die durch die allgemeine Immunantwort verursacht werden |
NZ552238A (en) * | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
CN102014917A (zh) * | 2008-02-22 | 2011-04-13 | 里格尔药品股份有限公司 | 2,4-嘧啶二胺用于治疗动脉粥样硬化的用途 |
DE202008007621U1 (de) * | 2008-06-04 | 2008-11-06 | Zimmer, Bruno | Kosmetisches und Nahrungsmittel aus unterschiedlichen Fettsäuren |
WO2011109472A1 (fr) * | 2010-03-02 | 2011-09-09 | Imagenetix, Inc. | Compositions comportant de l'acide myristique et leurs utilisations |
US8618095B2 (en) * | 2010-04-13 | 2013-12-31 | Rigel Pharmaceuticals, Inc. | 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
ITMI20111284A1 (it) * | 2011-07-11 | 2013-01-12 | Giovanni Nusca | Composizione farmaceutica. |
EP2850062B1 (fr) | 2012-05-18 | 2017-07-19 | Sanofi | Derives de pyridine utiles dans le traitement de conditions associees a formation pathologique des thrombes |
ITMI20130354A1 (it) | 2013-03-08 | 2014-09-09 | Again Life Italia Srl | Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie. |
CN103242262A (zh) * | 2013-05-24 | 2013-08-14 | 厦门大学 | N-脂肪酰基乙醇胺水解酶抑制剂及其合成方法和用途 |
-
2015
- 2015-08-03 CA CA2957700A patent/CA2957700C/fr active Active
- 2015-08-03 MA MA040417A patent/MA40417A/fr unknown
- 2015-08-03 JP JP2017508099A patent/JP7118642B2/ja active Active
- 2015-08-03 DK DK15754028.7T patent/DK3177281T3/da active
- 2015-08-03 CN CN201580042308.5A patent/CN106714792A/zh active Pending
- 2015-08-03 FI FIEP15754028.7T patent/FI3177281T3/fi active
- 2015-08-03 WO PCT/IB2015/055885 patent/WO2016020828A1/fr active Application Filing
- 2015-08-03 US US15/502,316 patent/US9962355B2/en active Active
- 2015-08-03 EP EP15754028.7A patent/EP3177281B1/fr active Active
- 2015-08-06 TW TW104125530A patent/TWI727926B/zh active
-
2017
- 2017-01-25 IL IL250271A patent/IL250271B2/en unknown
- 2017-02-06 CO CONC2017/0001088A patent/CO2017001088A2/es unknown
-
2018
- 2018-04-06 US US15/946,950 patent/US10149827B2/en active Active
-
2020
- 2020-10-13 JP JP2020172613A patent/JP7335475B2/ja active Active
-
2023
- 2023-01-31 JP JP2023012916A patent/JP2023041806A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20170224645A1 (en) | 2017-08-10 |
TWI727926B (zh) | 2021-05-21 |
DK3177281T3 (da) | 2024-03-11 |
IL250271B (en) | 2022-10-01 |
CN106714792A (zh) | 2017-05-24 |
WO2016020828A1 (fr) | 2016-02-11 |
JP7335475B2 (ja) | 2023-08-30 |
IL250271A0 (en) | 2017-03-30 |
CO2017001088A2 (es) | 2017-04-28 |
IL250271B2 (en) | 2023-02-01 |
US20180243254A1 (en) | 2018-08-30 |
TW201609084A (zh) | 2016-03-16 |
JP2021004260A (ja) | 2021-01-14 |
US9962355B2 (en) | 2018-05-08 |
JP7118642B2 (ja) | 2022-08-16 |
JP2017523230A (ja) | 2017-08-17 |
BR112017002474A2 (pt) | 2017-12-05 |
CA2957700C (fr) | 2022-12-13 |
EP3177281B1 (fr) | 2023-12-06 |
CA2957700A1 (fr) | 2016-02-11 |
FI3177281T3 (fi) | 2024-03-13 |
EP3177281A1 (fr) | 2017-06-14 |
JP2023041806A (ja) | 2023-03-24 |
US10149827B2 (en) | 2018-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA40417A (fr) | Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques | |
MY165048A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
HK1243324A1 (zh) | ω3脂肪酸的自乳化組合物 | |
ZA201704820B (en) | Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids | |
CY1122248T1 (el) | Μιγμα λιπαρων οξεων προς χρηση στη θεραπευτικη αγωγη φλεγμονωδων παθολογιων | |
MX2016004487A (es) | Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. | |
ZA201704821B (en) | Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids | |
MX2014000770A (es) | Composiciones de acidos grasos. | |
MX2015011767A (es) | Composiciones de aceite crudo de algas. | |
GEP201606568B (en) | Compositions for the treatment of neurologic disorders | |
ZA201702385B (en) | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states | |
GB201611497D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
TW201613571A (en) | OMWGA-3 compositions, dosage forms, and methods of use | |
PL3560342T3 (pl) | Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha | |
PT2952209T (pt) | Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral | |
GB201611503D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
PL3455351T3 (pl) | Sposób zwiększania wytwarzania wielonienasyconych kwasów tłuszczowych omega-3 w mikroalgach | |
GB201611500D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
GB201611499D0 (en) | Compositions for use in enriching animal meat with omega-3 polyunsaturated fatty acids | |
GB201607617D0 (en) | Use of EPA and DHA Omega3 Dietary supplementation and Omega6 polyunsaturated fatty acid dietary restriction to cure 2 type diabetes | |
AR095832A1 (es) | Composición farmacéutica oral útil para el trastorno del déficit de atención e hiperactividad, suplemento nutricional y alimento que la comprenden y proceso para preparar la composición | |
SG10202103821WA (en) | SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID | |
RU2011122400A (ru) | Амиды полиненасыщенных жирных кислот, снижающие агрегацию тромбоцитов |